AZD4573 |
| Katalog-Nr.GC32717 |
AZD4573 ist ein potenter und hochselektiver CDK9-Inhibitor (IC50 von <4 nM), der eine transiente Zielerfassung zur Behandlung hÄmatologischer Malignome ermÖglicht.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2057509-72-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
AZD4573 is a CDK9 inhibitor with an IC50 of <3 nM extracted from patent US 20160376287 A1, example 14.
[1]. Bernard Barlaam, et al. Chemical Compounds. US 20160376287 A1.
Review for AZD4573
Average Rating: 5 (Based on Reviews and 36 reference(s) in Google Scholar.)
Review for AZD4573
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *